Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
high blood pressure; This is a spontaneous report received from a Consumer or other non HCP from medical information team. An elderly female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "lupus" (unspecified if ongoing); "lactose intolerant" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HYPERTENSION (non-serious), outcome "unknown", described as "high blood pressure". Relevant laboratory tests and procedures are available in the appropriate section. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500181397 same reporter/patient, different dose/AE;
Medical History/Concurrent Conditions: Lactose intolerant; Lupus erythematosus
Test Name: blood pressure; Result Unstructured Data: Test Result:high